Compass Pathways Stock (NASDAQ: CMPS) stock price, news, charts, stock research, profile.
Open | $9.330 |
Close | $8.320 |
Volume / Avg. | 3.564M / 679.928K |
Day Range | 8.120 - 9.350 |
52 Wk Range | 5.010 - 12.750 |
Market Cap | $544.648M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 7.08% |
Days to Cover | 4.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Compass Pathways (NASDAQ: CMPS) through any online brokerage.
Other companies in Compass Pathways’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Korro Bio (NASDAQ:KRRO), Pharming (NASDAQ:PHAR) and Tevogen Bio Holdings (NASDAQ:TVGN).
The latest price target for Compass Pathways (NASDAQ: CMPS) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 120.00 expecting CMPS to rise to within 12 months (a possible 1315.09% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Compass Pathways (NASDAQ: CMPS) is $8.48 last updated March 28, 2024 at 7:31 PM EDT.
There are no upcoming dividends for Compass Pathways.
Compass Pathways’s Q4 earnings are confirmed for Thursday, February 23, 2023.
There is no upcoming split for Compass Pathways.
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.